In case you missed them, here are last week’s healthcare news highlights:
National Institute of Cancerology warns of oral cancer.
ISSSTE announces several initiatives within its campaign “February, Month of Men’s Health.”
AMIIF starts its first week of pharmaceutical innovation.
Brazilian authorities approve merger of Bayer and Monsanto.
Teva Pharmaceuticals reports drop in fourth quarter profits and warns of rocky 2018 to come.
Bristol-Myers reports success in key trial for Opdivo, a drug for non-small cell lung cancer.